Atelerix and Rodon Global Join Forces to Transform Cell Transport

Atelerix, renowned for its revolutionary hydrogel encapsulation technology, has partnered with South African logistics leader Rodon Global to revolutionize the transport and preservation of biomaterials. The collaboration integrates Atelerix’s cryo-free solutions into Rodon’s logistics services, initially expanding across the US, UK, South Africa, and Singapore. This groundbreaking agreement promises to enhance efficiency in drug discovery and clinical research by offering a sustainable alternative to traditional cold-chain logistics.

Atelerix’s innovative hypothermic preservation technology allows biological samples to stay at ambient temperatures for up to two weeks. This method addresses common logistics challenges by stabilizing cells without freezing, thus reducing energy consumption and waste. It’s particularly beneficial for cell and gene therapy manufacturing, offering a seamless solution throughout the workflow. The partnership with Rodon comes as the logistics firm broadens its reach across major global markets. This move follows Atelerix’s recent collaboration with MineBio in China, solidifying their presence in Asia and strengthening their global logistics network.